Long-acting PTH compound therapy

The present application relates to long-acting PTH compounds useful for reducing bone mineral density (BMD) in patients with increased BMD, as well as specific dosing regimens and other related aspects of such long-acting PTH compounds. 本申请涉及用于在具有增加的BMD的患者中降低骨矿物质密度(BMD)的长效PTH化合物，以及这种长效PTH化合物的特定给药方案和...

Full description

Saved in:
Bibliographic Details
Main Author SPROGOE KENNETT
Format Patent
LanguageChinese
English
Published 21.06.2024
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present application relates to long-acting PTH compounds useful for reducing bone mineral density (BMD) in patients with increased BMD, as well as specific dosing regimens and other related aspects of such long-acting PTH compounds. 本申请涉及用于在具有增加的BMD的患者中降低骨矿物质密度(BMD)的长效PTH化合物，以及这种长效PTH化合物的特定给药方案和其他相关方面。
Bibliography:Application Number: CN202280075450